Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dual NK1 and NK2 receptor antagonists under study at Sankyo for respiratory disorders, incontinence

Nov. 20, 1998

Zeneca files sNDA for Accolate asthma therapy

Nov. 20, 1998

ML Laboratories granted second license from U.K. authorities for its dry powder inhaler

Nov. 17, 1998

Novel Astra compounds inhibit mast cell, neutrophil and eosinophil activation

Nov. 16, 1998

New data show rhuMAb-E25 may reduce seasonal allergy symptoms

Nov. 13, 1998

NK2 antagonist from Zeneca blocks increased pulmonary resistance in guinea pigs

Nov. 12, 1998

Cytel's VLA4 antagonist shows potential for treating allergic lung inflammation

Nov. 11, 1998

Pyridyl compounds claimed by Astra for the Rx of asthma and rhinitis

Nov. 11, 1998

Positive phase II results reported for potential asthma treatment

Nov. 11, 1998

Preclinical pharmacokinetics of MEN-11420 determined in rats; compound advances to clinical trials

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...